George Gauthier - 04 Apr 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Signature
/s/ Fred Schwarzer, by power of attorney
Issuer symbol
IGMS
Transactions as of
04 Apr 2023
Net transactions value
-$11,781
Form type
4
Filing time
06 Apr 2023, 21:39:14 UTC
Previous filing
16 Mar 2023
Next filing
20 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +16,250 +88% $0.000000 34,813 04 Apr 2023 Direct F1
transaction IGMS Common Stock Sale $11,781 -935 -2.7% $12.60 33,878 05 Apr 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Stock Option (right to buy) Award $0 +32,500 $0.000000 32,500 04 Apr 2023 Common Stock 32,500 $12.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2024 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
F2 The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan, entered into on December 29, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F3 1/48 of the shares subject to the option shall vest on April 12, 2023 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.